|
P.B. Khishtilova, D.F. Sergienko
Effect of SFTPD gene rs721917 polymorphism on the course and outcomes of bronchopulmonary dysplasia in children
|
№9 / 2020
|
|
L.M. Alimbarova (1), I.V. Kukes (2)
Evaluation of the antiviral activity of benzydamine hydrochloride and its finished dosage form Tantum® Verde against herpes simplex virus types 1 and 2
|
№9 / 2020
|
|
N.V. Breslav (1), E.S. Kirillova (1), I.V. Kukes (2), E.I. Burtseva (1)
Antiviral activity of Tantum Verde And its active substance benzydamine hydrochloride against influenza virus in vitro
|
№9 / 2020
|
|
L.V. Osidak, E.G. Golovacheva, O. I. Afanasyeva, E.A. Smorodintseva, V.V. Gonchar, E.V. Obraztsova, E.S. Goncharova, K.A. Stolyarov
Treatment of ARVI in young children
|
№9 / 2020
|
|
A.R. Savkina (1), M.A. Kareva (2), M.A. Melikyan (2)
Long-acting somatostatin analogues in the treatment of children with congenital hyperinsulinism. Literature review
|
№9 / 2020
|
|
A.L. Zaplatnikov (1), A.A. Girina (2), I.V. Lepiseva (3), V.I. Svintsitskaya (1)
Topical bacterial lysates in pediatric practice
|
№9 / 2020
|
|
A.N. Surkov (1, 2, 3)
Algorithm for the treatment of functional constipation in children: modern concepts
|
№9 / 2020
|
|
V.A. Bulgakova (1), E.N. Kareva (2, 3), L.R. Selimzyanova (3, 4), T.E. Privalova (2, 4)
Antihistamines in pediatric practice: what we need to know?
|
№9 / 2020
|
|
S.B. Erofeeva (1, 3), E.P. Smirnova (2, 3)
Review of clinical guidelines for the treatment of children with confirmed coronavirus infection COVID-19: a clinical pharmacologist’s view
|
№9 / 2020
|
|
E.V. Svechnikova, Z.B. Marshani
Clinical case of mycosis fungoides
|
№8 / 2020
|
|
E.V. Ikonnikova, M.A. Avagumyan
The possibilities of fractional laser therapy and physiotherapy in the treatment and prevention of hyperpigmentation
|
№8 / 2020
|
|
A.A. Khotko, M.Yu. Pomazanova
Description of the clinical case of the use of the apremilast in a patient with an oncological history
|
№8 / 2020
|
Русский
